Fabino Life Sciences Ltd Directors Report

To The Members,

Your Directors take pleasure in presenting their Eleventh Annual Report on the Business and Operations of the Company and the Accounts for the Financial Year ended 31st March, 2023 (period under review).

1. FINANCIALPERFORMANCE OF THE COMPANY:

The summary of the financial performance for the financial year ended March 31, 2023 and the previous financial year ended March 31, 2023 is given below:

(Rs. in lakhs)

Particulars	31-Mar-23	31-Mar-22
Total Income	338.26	421.28
Less: Expenditure	336.30	414.68
Profit before Depreciation	1.96	6.59
Less: Depreciation	3.16	3.12
Profit before Tax	1.96	6.59
Provision for Taxation	0.32	1.88
Profit after Tax	1.64	4.70
Other Comprehensive Income	-	-
Total Comprehensive Income	1.64	4.70
Earnings Per Share (FV of Rs.10/- per share)
(1) Basic	0.27	0.78
(2) Diluted	0.27	0.78

2. REVIEW OF OPERATIONS

The Total Income of the Company stood at Rs. 338.26 lakhs for the year ended March 31, 2023 as against Rs.421.28 lakhs in the previous year. The Company made a net profit (after tax) of Rs 1.64 lakhs for the year ended March 31, 2023 as compared to the Rs. 4.70 lakhs in the previous year.

3. CASH FLOW AND CONSOLIDATED FINANCIAL STATEMENTS:

As required under regulation 34 of the SEBI (LODR) Regulations, 2015, a Cash Flow Statement forms part of Annual Report.

4. TRANSFER TO RESERVES IN TERMS OF SECTION 134 (3) (J) OF THE COMPANIES ACT, 2013

The Board has decided not to transfer any amount to the Reserves for the year under review.

5. DIVIDEND:

The dividend policy for the year under review has been formulated taking into consideration of growth of the company and to conserve resources, the Directors do not recommend any dividend for year ended March 31, 2023.

6. TRANSFER OF UNPAID AND UNCLAIMED DIVIDENDS TO INVESTOR EDUCATION AND PROTECTION FUND

The Ministry of Corporate Affairs under Sections 124 and 125 of the Companies Act, 2013 requires dividends that are not encashed/ claimed by the shareholders for a period of seven consecutive years, to be transferred to the Investor Education and Protection Fund (IEPF). In FY 2022-23, there was no amount due for transfer to [IEPF

7. SHARE CAPITAL

The authorized share capital of the company is Rs. 12,00,00,000/- divided into 1,20,00,000 equity shares of Rs. 10/- The Paid up capital of the Company is Rs. 2,10,00,000/- divided into 21,00,000 Equity shares of Rs. 10/- Company has appointed M/s Bigshare Services Private Limited as the Registrar and Transfer Agent of the Company.

8. MANAGEMENTS DISCUSSION AND ANALYSIS REPORT:

The details pertaining to overview of the industry, important changes in the industry, external environment and outlook along with other information as required are given in the Management Discussion and Analysis Report, which forms part of this Annual Report.

9. CHANGE IN NATURE OF BUSINESS, IF ANY

There has been no change in nature of business of the Company during the FY under review.

10. DISCLOSURES BY DIRECTORS

The Board of Directors have submitted notice of interest in Form MBP 1 under Section 184(1) as well as intimation by directors in Form DIR 8 under Section 164(2) and declarations as to compliance with the Code of Conduct of the Company.

11. SUBSIDIARY/ JOINT VENTURE/ ASSOCIATE COMPANY

The Company have a Upender Metaplast Private Limited as Subsidiary, Joint venture or an Associate Company.

12. MATERIAL CHANGES AND COMMITMENTS

There have been no material changes and commitments, which affect the financial position of the Company which have occurred between the end of the FY and the date of this Report.

13. EXTRACT OF ANNUAL RETURN:

The Annual Return of the Company as on 31% March, 2023 is available on the website of the Company at www. fabinolife.com

14. CHANGE IN SHARE CAPITAL:

There was no change in Share Capital for year ended March 31, 2023.

15. FAMILIARISATION PROGRAMME FOR DIRECTORS

As a practice, all Directors (including Independent Directors) inducted to the Board go through a structured orientation programme. Presentations are made by Senior Management giving an overview of the operations, to familiarise the new Directors with the Companys business operations. The Directors are given an orientation on the products of the business, group structure and subsidiaries, Board constitution and procedures, matters reserved for theBoard, and the major risks and risk management strategy of the Company.

During the year under review, no new Independent Directors were inducted to the Board.

16. DIRECTORS AND KEY MANAGERIAL PERSONNEL:

i. Change in Directors

Name of the Director	Date of Change	Reason for Change
Mr. Sumit Malik	May 24, 2022	Appointed as Additional Non-Executive Non- Independent Director
Aditya Mahavir Jain	December 06, 2021	Re-designated as Non-Executive Director
Atul Kumar Jain	November 10, 2021	Re-designated as Chairperson and Managing Director
Kuldeep Solanki	November 10, 2021	Re-Appointed as Non-Executive Independent Director
Aditya Mahavir Jain	October 27, 2021	Regularised as Whole time Director
Gagan Gupta	October 27, 2021	Regularised as Non-Executive Independent Director
Tesu Alakh	October 27, 2021	Regularised as Non-Executive Independent Director
Aditya Mahavir Jain	October 18, 2021	Appointed as Additional Executive Director
Gagan Gupta	October 18, 2021	Appointed as Additional Non-Executive Independent . Director
Tesu Alakh	October 18, 2021	Appointed as Additional Non-Executive Independent Director
Kuldeep Solanki	October17, 2021	Cessation Non-Executive Independent Director

ii. Change in Key Managerial Personnel

Name	Designation	Date of Appointment / i e	Reason
Aslam Mohammad	Company Secretary & Compliance Officer	August 11, 2022	Resignation
Kanchi Gehlot	Company Secretary & Compliance Officer	May 02, 2023	Appointment
Sumit Malik	Non-Executive Non- Independent Director	September 22,2022	Appointment

iii. Committees of Board of Directors

Sr. No. Date	Committee	Director Name
		Mrs. Tesu Alakh (Chairman)
November 13, 2021	Audit Committee	Mr. Gagan Gupta (Member)
		Mr. Atul Kumar Jain (Member)
		Mrs. Tesu Alakh (Chairman)
November 13, 2021	Nomination and Remuneration Committee	Mr. Gagan Gupta (Member)
		Mr. Arihant Jain (Member)
		Mr. Arihant Jain(Chairman)
November 13, 2021	Stakeholder Relationship Committee	Mr. Gagan Gupta (Member)
		Mr. Atul Kumar Jain (Member)

iv. Retirement by Rotation of the Directors

In accordance with the provisions of the Companies Act, 2013 and the Articles of Association of the Company, Mr. Aditya Jain, Non-Executive Director of the Company, retires by rotation and offers himself for re- appointment.

The brief resume of Mr. Aditya Jain, the nature of his expertise in specific functional areas, names of the companies in which he has held directorships, his shareholding etc. are furnished in the Annexure - A to the notice of the ensuing AGM.

Independent Directors

Our Company has received annual declarations from all the Independent Directors of the Company confirming that they meet with the criteria of Independence provided in Section 149(6) of the Companies Act, 2013 and Regulations 16(1) (b) & 25 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and there has been no change in the circumstances, which may affect their status as Independent Director during the year.

The Independent Directors met on 24" March, 2023, without the attendance of Non-Independent Directors and members of the Management. The Independent Directors reviewed the performance of Non-Independent Directors and the Board as a whole; the performance of the Chairman of the Company, taking into account the views of Executive Directors and Non-Executive Directors and assessed the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties.

17. BOARD MEETINGS:

The Company held six meetings of its Board of Directors during the year on 24h May, 2022, 25% July, 2022,11% August, 2022, 26" August, 2022, 9th November, 2022, 24" February, 2023.

18. COMMITTEES OF THE BOARD:

(a) Audit Committee:

Our Board has constituted the Audit Committee vide Board Resolution dated November 13, 2021 in accordance with the Section 177 of the Companies Act, 2013. The audit committee comprises of:

			Attendance at the Audit Committee Meeting held on
Name of the Directors	Nature of Directorship	Designation in Committee	24.05.2022	26.08.2022	09.11.2022
Tesu Alakh	Non } Executive Independent Director	Chairman	Yes	Yes	Yes
Gagan Gupta	Non - Executive Independent Director	Member	Yes	Yes	Yes
Atul Kumar Tai Jain	Chairman and Managing . Director	Member	Yes	Yes	Yes

The Committee is governed by a Charter, which isin line with the regulatory requirements mandated by the Companies Act, 2013. Some of the important functions performed by the Committee are:

Financial Reporting and Related Processes: eo Oversight of the Companys financial reporting process and financial information submitted to the Stock Exchanges, regulatory authorities or the public. e? Reviewing with the Management, the Half Yearly Unaudited Financial Statements and the Auditor‘s Limited Review Report thereon / Audited Annual Financial Statements and AuditorsR Report thereon before submission to the Board for approval. This would, inter alia, include reviewing changes in the accounting policies and reasons for the same, major accounting estimates based on exercise of judgement by the Management, significant adjustments made in the Financial Statements and / or recommendation, if any, made by the Statutory Auditors in this regard. e Review the Management Discussion & Analysis of financial and operational performance. e Discuss with the Statutory Auditors its judgement about the quality and appropriateness of the Companys accounting principles with reference to the Accounting Standard (AS).

? Review the investments made by the Company.

All the Members on the Audit Committee have the requisite qualification for appointment on the Committee and possess sound knowledge of finance, accounting practices and internal controls.

(b) Nomination and Remuneration Committee:

Our Board has constituted the Nomination and Remuneration Committee vide Board Resolution November 13, 2021 in accordance with section 178 of the Companies Act, 2013. The Nomination and Remuneration Committee comprises of:

Name of the Directors	Nature of Directorship	Designation in Committee	Attendance at the BYTE 2 a RGer Committee Meeting held on 24.05.2022	Attendance at the einai and INGE Committee Meeting held on 11.08.2022
Tesu Alakh	Non Executive Independent Director	Chairman	Yes	Yes
Gagan Gupta	Non Executive Independent Director	Member	Yes	Yes
Arihant Jain	Non Executive Director	Member	Yes	Yes

The terms of reference of the Committee inter alia, include the following:

Succession planning of the Board of Directors and Senior Management Employees;

Identifying and selection of candidates for appointment as Directors / Independent Directors based on certain laid down criteria;

Identifying potential individuals for appointment as Key Managerial Personnel and to other Senior Management positions;

Formulate and review from time to time the policy for selection and appointment of Directors, Key Managerial

Personnel and senior management employees and their remuneration;

Review the performance of the Board of Directors and Senior Management Employees based on certain criteria as approved by the Board.

The Company has formulated a Remuneration Policy which is annexed to the Board*s Report in -Annexure I”.

c Stakeholders Relationship Committee:

Our Board has constituted the StakeholdersR Relationship Committee vide Board Resolution November 13, 2021 and re-constituted on December 08, 2021 in accordance with Section 178 of the Companies Act, 2013. The Stakeholders Relationship Committee comprises of:

Name of the Directors	Nature of Directorship	Designation in pai tee	Attendance at the Stakeholders Relationship Committee Meeting held on 24.05.2022
Arihant Jain	Non-Executive Director	Chairman	Yes
Atul Kumar Jain	Chairman and Managing Director	Member	Yes
Gagan Gupta	Non - Executive Independent Director	Member	Yes

The terms of reference of the Committee are:

e transfer/transmission of shares/debentures and such other securities as may be issued by the Company from time to time;

e issue of duplicate share certificates for shares/debentures and other securities reported lost, defaced or destroyed, as per the laid down procedure;

e issue new certificates against subdivision of shares, renewal, split or consolidation of share certificates / certificates relating to other securities;

e issue and allot right shares / bonus shares pursuant to a Rights Issue / Bonus Issue made by the Company, subject to such approvals as may be required,

e to grant Employee Stock Options pursuant to approved Employees Stock Option Scheme(s), if any, and to allot shares pursuant to options exercised,

e to issue and allot debentures, bonds and other securities, subject to such approvals as may be required,

e to approve and monitor dematerialization of shares / debentures / other securities and all matters incidental or related thereto;

e to authorize the Company Secretary and Head Compliance / other Officers of the Share Department to attend to matters relating to non-receipt of annual reports, notices, non-receipt of declared dividend / interest, change of address for correspondence etc. and to monitor action taken;

e monitoring expeditious redressal of investors / stakeholders grievances;

e all other matters incidental or related to shares, debenture

During the year, no complaints were received from shareholders. There are no balance complaints. The Company had no share transfers pending as on March 31, 2023

Ms. Kanchi Gehlot, Company Secretary of the Company is the Compliance Officer.

19. BOARDS PERFORMANCE EVALUATION:

The Board of Directors carried out an annual evaluation of the Board itself, its Committees and individual Directors. The entire Board carried out performance evaluation of each Independent Director excluding the IndependentDirector being evaluated.

The evaluation was done after taking into consideration inputs received from the Directors, setting out parameters of evaluation. Evaluation parameters of the Board and Committees were mainly based on Disclosure of Information, Key functions of the Board and Committees, Responsibilities of the Board and Committees, etc. Evaluation parameters of Individual Directors including the Chairman of the Board and Independent Directors were based on Knowledge to Perform the Role, Time and Level of Participation, Performance of Duties and Level of Oversight and Professional Conduct etc.

Independent Directors in their separate meeting evaluated the performance of Non-Independent Directors, Chairman of the Board and the Board as a whole.

20. CORPORATE SOCIAL RESPONSIBILITY

The Company does not fall under the criteria laid under the provisions of Section 135 of the Act and rules framed there under. Therefore, the provisions of Corporate Social Responsibility are not applicable to the Company.

21. AUDITORS:

i. Statutory Auditors:

Subject to the amendment stated in The Companies Amendment Act, 2017 read with Notification S.O. 1833(E) dated 8" May 2018 deleting the provision of annual ratification of the appointment of auditor, the requirement to place the matter relating to appointment of Auditors for ratification by members at every Annual General Meeting is done away with and no resolution has been proposed for the same.

ii. Secretarial Auditor:

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company has appointed ING & CO., a firm of Company Secretaries in Practice (CP No. 8108), to undertake the Secretarial Audit of the Company for the F.Y. 2022-23 . The Secretarial Audit Report for F.Y. 2022-23 is annexed herewith as “Annexure II”.

iii. Cost Auditor:

The company does not fall within the provisions of Section 148 of Company*s Act, 2013 read with the Companies (Cost records & Audit) Rules, 2014, therefore such records are duly maintained.

iv. Internal Auditor:

The Board appointed M/s. B B Gusani and Associates, Chartered Accountant, as the Internal Auditor of the Company for the FY 2022-2023.

22. AUDITORS REPORT:

The Auditors Report and Secretarial Auditor‘s Report does not contain any qualification, reservations or adverse remarks. Report of the Secretarial Auditor is given as an Annexure which forms part of this report.

23. VIGIL MECHANISM/WHISTLE BLOWER POLICY:

In pursuant to the provisions of section 177(9) & (10) of the Companies Act, 2013, a Vigil Mechanism for Directors and Employees to report genuine concerns has been established. The Vigil Mechanism Policy has been uploaded on the website of the Company at www. fabinolife.com.

24. INTERNAL AUDIT & CONTROLS:

Pursuant to provisions of Section 138 read with rules made there under, the Board has appointed M/s. B B Gusani And Associates, Chartered Accountants, as an Internal Auditors of the Company to check the internal controls and functioning of the activities and recommend ways of improvement. The Internal Audit is carried out on half yearly basis; the report is placed in the Audit Committee Meeting and the Board Meeting for their consideration and direction.

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. During the year under review, no material or serious observation has been received from the Internal Auditors of the Company for inefficiency or inadequacy of such controls.

Based on the framework of internal financial controls and compliance systems established and maintained by the Company, work performed by the internal, statutory and secretarial auditors and external consultants and the reviews performed by management and the relevant board committees, including the audit committee, the board is of the opinion that the Companys internal financial controls were adequate and effective during the financial year 2022-23.

25. RISK ASSESSMENT AND MANAGEMENT:

Your Company has been on a continuous basis reviewing and streamlining its various operational and business risks involved in its business as part of its risk management policy. Your Company also takes all efforts to train its employees from time to time to handle and minimize these risks.

26. LISTING WITH STOCK EXCHANGES:

Fabino Life Sciences Limited is listed on the SME Platform of the BSE Limited. It has paid the Annual Listing Fees for the year 2022-23 to BSE Limited.

27. COMPLIANCE WITH SECRETARIAL STANDARDS:

The Company is fully compliant with the applicable Secretarial Standards (SS) viz. SS-1 & SS-2 on Meetings of the Board of Directors and General Meetings respectively.

28. *PARTICULARS OF EMPLOYEES AND REMUNERATION

The information required under Section 197 & Rule 5 of the Companies (Appointment and Remuneration ofManagerial Personnel) Rules, 2014 is given below.

a) The median remuneration of employees of the Company during the financial year was Rs. 1,44,000 b) Percentage increase/(decrease) in the median remuneration of employees in the financial year 2022-23: - 60%

?) Number of permanent employees on the rolls of the Company as on March 31, 2023:10 (Ten) d) It is hereby affirmed that the remuneration paid during the year is as per the Remuneration policy of the Company. e) There is no employee covered under the provisions of section 197(14) of the Companies Act, 2013.

There was no employee in the Company who drew remuneration of Rs. 1,00,00,000/ - per annum during the period under review. Hence, the Company is not required to disclose any information as per Rule 5(2) of the Companies (Appointment and Remuneration) Rules, 2014.

29. POLICIES AND DISCLOSURE REQUIREMENTS:

In terms of provisions of the Companies Act, 2013 the Company has adopted following policies which are available on its website www. fabinolife.com

30. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN

EXCHANGE EARNINGS AND OUTGO:

i. Conservation of Energy

a) The steps taken or impact on conservation of energy The Operations of the Company are not energy intensive. However, adequate measures have been initiated for conservation of energy. b) The steps taken by the Company for utilizing alternate source of energy Company shall consider on adoption of alternate source of energy as and when necessities.

?) The Capital Investment on energy conversation equipment No Capital Investment vet. ii. Technology absorption

a) The efforts made towards technology absorption. Minimum technology required for Business is absorbed.

b) The benefits derived like product improvement, cost reduction, product development or import substitution Not Applicable.

?) In case of imported technology (imported during the last three years reckoned from the beginning of the financial year) Not Applicable.

a. the details of technology imported,

b. the year of import;

?. whether the technology been fully absorbed,

d. if not fully absorbed, areas where absorption has not taken place, and the reasons thereof

iii. The expenditure incurred on Research and Development Not Applicable.

31. PARTICULARS OF LOANS, INVESTMENTS AND GUARANTEES:

Particulars of loans given, investments made, guarantees given and securities provided are provided in the financial statements.

32. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

All contracts / arrangements / transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on an arm‘s length basis. Thus Disclosure in form AOC-2 is not required. Further, during the year, the Company had not entered into any contract / arrangement / transaction with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions. All related party transactions are placed before the Audit Committee and Board for approval. The details of the related party transactions as required under Accounting Standard (AS) are set out in Note to the financial statements forming part of this Annual Report.

33. DEPOSITS:

Your Company did not accept / hold any deposits from public / shareholders during the year under review.

34. PREVENTION OF INSIDER TRADING:

In compliance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended, the Company has formulated and adopted the revised Code of Conduct for Prevention of Insider Trading ( the Insider Trading Codel). The object of the Insider Trading Code is to set framework, rules and procedures which all concerned persons should follow, while trading in listed or proposed to be listed securities of the Company. During the year, the Company has also adopted the Code of Practice and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ( the Codel) in line with the SEBI (Prohibition of Insider Trading) Amendment Regulations, 2018. The Code is available on the Company*s website www. fabinolife.com

35. RELATED PARTY TRANSACTIONS

All transactions entered into with related parties as defined under the Act during the FY were in the ordinary course of business and on an arm‘s length pricing basis and do not attract the provisions of Section 188 of the Act. There were no materially significant transactions with the related parties during the FY which were in conflict with the interest of the Company

36. SIGNIFICANT AND MATERIAL ORDERS:

There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Companys operations in future.

37. FRAUD REPORTING

There have been no frauds reported by the Auditors of the Company to the Audit Committee or the Board of Directors under sub-section (12) of section 143 of the Companies Act, 2013 during the financial year.

38. OBLIGATION OF COMPANY UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has in place an Anti-Sexual Harassment Policy in line with the Requirements of the Sexual Harassment of Women at the Workplace (Prevention, Prohibition & Redressal) Act, 2013and and Internal Complaints Committee has been set up to redress complaints received regarding Sexual Harassment at workplace, with a mechanism of lodging & redresses the complaints. All employees (permanent, contractual, temporary, trainees, etc.) are covered under this policy. Policy is available on website of company at www.fabinolife.com

Your Directors further state that pursuant to the requirements of Section 22 of Sexual Harassment of Women at Work place (Prevention, Prohibition &Redressal) Act, 2013 read with Rules there under, the Company has not received any complaint of sexual harassment during the year under review.

39. HUMAN RESOURCES:

Your Company has established an organization structure that is agile and focused on delivering business results. With regular communication and sustained efforts it is ensuring that employees are aligned on common objectives and have the right information on business evolution.

40. CORPORATE GOVERNANCE:

In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 exempts companies which have listed their specified securities on SME Exchange from compliance with corporate governance provisions.

Since the equity share capital of your Company is listed exclusively on the SME Platform of BSE, the Company is exempted from compliance with Corporate Governance requirements, and accordingly the reporting requirements like Corporate Governance Report, Business Responsibility Report etc. are not applicable to the Company.

41. DIRECTORS" RESPONSIBILITY STATEMENT:

Pursuant to Section 134(5) of the Companies Act, 2013, the board of directors, to the best of their knowledge and ability, confirm that:

1. In the preparation of the annual accounts, the applicable accounting standards have been followed and there are no material departures.

il. They have selected such accounting policies and applied them consistently and made judgments andestimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

il. They have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing anddetecting fraud and other irregularities.

iv. They have prepared the annual accounts on a going concern basis.

v. They have laid down internal financial controls to be followed by the Company and such internal financial controls are adequate and operating effectively.

Vi. They have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

Based on the framework of internal financial controls and compliance systems established and maintained by the Company, work performed by the internal, statutory and secretarial auditors and external consultants and the reviews performed by management and the relevant board committees, including the audit committee, the board is of the opinion that the Company*s internal financial controls were adequate and effective during the financial year 2022-23.

42. CAUTIONARY STATEMENTS:

Statements in this Annual Report, particularly those which relate to Management Discussion and Analysis asexplained in the Corporate Governance Report, describing the Companys objectives, projections, estimates and expectations may constitute _forward looking statementsR within the meaning of applicable laws and regulations. Actual results might differ materially from those either expressed or implied in the statement depending on the circumstances.

43. ACKNOWLEDGEMENTS:

Your Directors would like to express deep sense of appreciation for the assistance and co-operation received from the Financial Institutions, Banks, Government Authorities and Shareholders and for the devoted service by the Executives, staff and workers of the Company. The Directors express their gratitude towards each one of them.

Registered Office:	On Behalf of The Board Of Directors
Jeevan Vihar Extension Near,
Shubham Garden, Murthal Road,	FOR FABINO LIFE SCIENCES LTD
Sonipat, Haryana-131001.
Tel : 9883900021
CIN: 1.24100HR2011PL.C114093
Website: www.fabinolife.com	Sd/-
J Tr	Atul Kumar Jain
Email: info@fabinolife.com	. .
	(Managing Director)
	DIN: 00004339
	Haryana, Friday, August 18, 2023